TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c01465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Tanja C Knaab und 15 weiteren Autor:innen. Beteiligte Einrichtung: Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutical and Medicinal Chemistry, Universitätss…. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Drug Resistance, Mice, SCID. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Malaria continues to pose a significant burden on populations in endemic areas and requires innovative treatment options. Here, we report the synthesis and preclinical evaluation of the novel 3-hydroxypropanamidine (HPA) 2 (TKK130), which shows excellent antiplasmodial in vitro activity against drug-sensitive and -resistant Plasmodium falciparum strains. Moreover, in various human cell lines, the compound shows no cytotoxicity and excellent parasite selectivity. The compound inhibits synthetic hemozoin (β-hematin) formation, with IC50 values lower than chloroquine (CQ), and its in vitro rate of activity is comparable with the fast-acting antimalarial drug dihydroartemisinin. Furthermore, selection studies reveal a very low propensity for resistance development. Based on initial in vivo pharmacokinetic snapshot data, 2 (TKK130) has a long-lasting, linear pharmacokinetic profile. In vivo, this novel HPA exhibits curative activity in the Plasmodium bergheimouse model and potent activity in theP. falciparum SCID mouse model after oral administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Heinrich Heine University Düsseldorf, Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutical and Medicinal Chemistry, Universitätsstr. 1, 40225 Düsseldorf, Germany.
- Individualized Pharmacotherapy, Institute of Pharmaceutical and Medicinal Chemistry, University of Muenster, 48149 Muenster, Germany.
- Institute of Tropical Medicine, Eberhard Karls University Tuebingen, 72074 Tuebingen, Germany.
- Department of Microbiology and Immunology and Center for Malaria Therapeutics and Antimalarial Resistance, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, Ne…
- Centre de Recherches Medicales de Lambaréné, Lambaréné, B.P 242 Lambaréné, Gabon.
- Department of Implementation Research, Bernhard Nocht Institute for Tropical Medicine and Department of Medicine, University Medical Centre Hamburg-Eppendorf, D-20359 Hamburg, Germany.
ORCID-Profile: Katherine A de Villiers, Bjoern B Burckhardt, Jana Held, Sergio Wittlin, Thomas Kurz
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Deutsche Forschungsgemeinschaft
- Medicines for Malaria Venture
Zitieren
APA
Knaab, T. C., Moritz, A., Pessanha de Carvalho, L., Klein, S., Lungerich, B., Lohse, K., Kruse, L., Mombo-Ngoma, G., Orta, L., Thibaud, J. L., de Villiers, K. A., Fidock, D. A., Burckhardt, B. B., Held, J., Wittlin, S., & Kurz, T. (2025). TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01465
Vancouver
Knaab TC, Moritz A, Pessanha de Carvalho L, Klein S, Lungerich B, Lohse K, et al. TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01465
BibTeX
@article{Knaab2025,
author = {Knaab, Tanja C and Moritz, Alena and Pessanha de Carvalho, Lais and Klein, Saskia and Lungerich, Beate and Lohse, Katharina and Kruse, Linn and Mombo-Ngoma, Ghyslain and Orta, Lily and Thibaud, Jessica L and de Villiers, Katherine A and Fidock, David A and Burckhardt, Bjoern B and Held, Jana and Wittlin, Sergio and Kurz, Thomas},
title = {TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c01465}
}
EUVIMED